Gurrola Sandra M 4
4 · Brooklyn ImmunoTherapeutics, Inc. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Gurrola Sandra M
VP of Finance
Transactions
- Award
Stock Option (Right to buy)
2022-03-11+114,500→ 114,500 totalExercise: $1.93Exp: 2032-03-11→ Common Stock (114,500 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter.